Stay updated on Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a new version of the page's documentation. This reflects a version update rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-07-04T13:11:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2, signaling a minor version update for the page. The user-facing content and study details appear unchanged, indicating a maintenance revision rather than a content change.
    Difference
    0.0%
    Check dated 2026-06-27T05:55:40.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now shows that recruitment is closed for the study and introduces new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) while standardizing the Interventions heading to 'Intervention/Treatment' and updating the revision tag to v3.6.0, replacing the prior v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-13T01:36:07.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's documentation/versioning rather than changes to the visible content.
    Difference
    0.0%
    Check dated 2026-06-05T22:44:13.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Footer metadata and indexing terms were expanded to include IPD sharing, FDA-regulated status, and additional related terms for indexing and search. No core study content or eligibility criteria were altered.
    Difference
    100%
    Check dated 2026-05-29T23:09:09.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Core sections including the Study Overview, locations and contacts, and study status were removed, leaving less information about the EV-103 urothelial cancer trial.
    Difference
    20%
    Check dated 2026-05-22T14:46:14.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.